SCHEMBL19937854

SCHEMBL19937854

CNCCOCCN(C)CCCOc1cccc(-c2cccc(OCCCN3CCCC3)c2C)c1C

nearest known ligand 0.46

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.46
CYP2C19 P33261 1/20 0.46
CD274 Q9NZQ7 7/20 0.43
ALDH1A1 P00352 5/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.41
HTT P42858 1/20 0.41
HTR1B P28222 1/20 0.41
DRD2 P14416 1/20 0.41
DRD1 P21728 1/20 0.41
DRD4 P21917 1/20 0.41
DRD5 P21918 1/20 0.41
HRH1 P35367 1/20 0.41
DRD3 P35462 1/20 0.41
HRH3 Q9Y5N1 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19897694 0.86 CD274 (0.47) CD274HRH1HRH3
SCHEMBL19897692 0.86 CD274 (0.47) CD274HRH1HRH3
SCHEMBL19937771 0.84 CYP2D6 (0.53) CYP2D6CYP2C19CD274ALDH1A1SMN1; SMN2
SCHEMBL19939389 0.83 CYP2D6 (0.52) CYP2D6CYP2C19CD274ALDH1A1SMN1; SMN2
SCHEMBL24445457 0.82 CD274 (0.47) CYP2D6CYP2C19CD274ALDH1A1L3MBTL1
SCHEMBL19916357 0.82 CD274 (0.47) CYP2D6CYP2C19CD274ALDH1A1L3MBTL1
SCHEMBL24445406 0.81 CYP2D6 (0.68) CYP2D6CYP2C19ALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL24445444 0.80 CYP2D6 (0.66) CYP2D6CYP2C19ALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL19916129 0.80 CYP2D6 (0.66) CYP2D6CYP2C19ALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL19939876 0.79 CYP2D6 (0.48) CYP2D6CYP2C19CD274ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3507284-B1 BIARYL COMPOUNDS USEFUL AS IMMUNOMODULATORS BRISTOL MYERS SQUIBB CO (US) 2022-05-25 EP disclosed
WO-2018044963-A1 BIARYL COMPOUNDS USEFUL AS IMMUNOMODULATORS BRISTOL-MYERS SQUIBB COMPANY (US) 2018-03-08 WO disclosed